Treace Medical Concepts, Inc. (TMCI) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 56.04M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 45.62M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 181.06M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $56.04M | (m) | $45.62M | $181.06M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $55.82M | (m) | $51.85M | $184.10M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $55.58M | (m) | $48.37M | $190.58M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $53.53M | (m) | $57.42M | $196.59M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $53.45M | (m) | $69.29M | $206.44M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $53.38M | (m) | $76.09M | $205.85M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $53.31M | (m) | $75.68M | $217.09M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $53.23M | (m) | $82.80M | $212.92M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $53.16M | (m) | $95.05M | $226.08M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $53.08M | (m) | $110.01M | $242.73M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $53.01M | (m) | $123.20M | $251.91M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $52.93M | (m) | $122.16M | $240.36M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $52.86M | (m) | $139.48M | $249.64M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $52.78M | (m) | $170.66M | $249.17M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $52.71M | (m) | $81.25M | $159.02M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $52.64M | (m) | (m) | $156.44M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $52.56M | (m) | (m) | $158.72M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $29.41M | (m) | (m) | $146.51M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $29.36M | (m) | (m) | $140.82M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $29.32M | (m) | (m) | $137.59M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $29.28M | (m) | (m) | $142.30M | (m) |
| 2021-03-31 | (m) | (m) | $0.00 | $29.23M | (m) | (m) | $37.38M | (m) |
| 2020-12-31 | (m) | (m) | $1.79M | $29.19M | (m) | (m) | $41.81M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |